For more than a decade, the United States has faced a relentless and heartbreaking increase in fatal drug overdoses driven by synthetic opioids. A new analysis suggests this trend has suddenly reversed due to a major disruption in the global supply chain of illicit fentanyl. Published in Science, the study indicates that regulatory actions taken by the Chinese government, following high-level diplomatic engagement with the Biden administration, may be the primary driver behind this unexpected decline in mortality.
The trajectory of the American overdose crisis has been grim for fifteen years. Deaths attributed to synthetic opioids rose more than 25-fold during that period. The annual toll reached a record high of 76,000 deaths in 2023. Yet, starting in the middle of that year, the numbers began to fall. By the end of 2024, the rate of fentanyl overdose deaths had dropped by more than one-third.
Public health officials and policymakers have struggled to explain this abrupt shift. It is often difficult to determine the cause of market fluctuations because illicit drug trafficking organizations operate in the shadows. To solve this puzzle, a team of researchers synthesized diverse data sets ranging from government seizure logs to social media discussions.
The research team was led by Kasey Vangelov at the University of Maryland. He worked alongside colleagues including Keith Humphreys of Stanford University and Peter Reuter of the University of Maryland. They sought to determine if the decline in deaths was the result of a “supply shock.” This economic term refers to a sudden event that drastically reduces the availability of a commodity.
Supply shocks have altered drug markets in the past. In the early 2000s, a drought in Australia’s heroin supply resulted in a 60 percent decline in opioid overdose mortality. Conversely, the introduction of fentanyl into North American markets around 2014 acted as a positive supply shock that increased mortality. The researchers hypothesized that a similar mechanism in the opposite direction might explain the current situation.
The investigators first examined traditional indicators of drug supply collected by the United States government. They analyzed data from the Drug Enforcement Administration regarding the purity of fentanyl seized by law enforcement. In illicit markets, dealers often respond to shortages by diluting their product rather than raising prices. This phenomenon is similar to the “shrinkflation” observed in legitimate retail sectors.
The data revealed a distinct pattern. The average purity of fentanyl powder seized by authorities rose throughout 2022 and peaked at roughly 25 percent in early 2023. Following that peak, purity levels plummeted. By the end of 2024, the average purity of seized powder had fallen to approximately 11 percent.
This decline in product quality occurred almost simultaneously with the drop in overdose deaths. The researchers found a strong correlation between the purity of fentanyl pills and the rate of fatal overdoses. As the drugs became less potent due to apparent shortages, fewer people died from using them.
The team also reviewed the number of drug seizures reported by the National Forensic Laboratory Information System. Seizures of fentanyl peaked in the first half of 2023. By the second half of 2024, those numbers had fallen by 37 percent. While fewer seizures could theoretically result from reduced police activity, the high political profile of the fentanyl crisis suggests that enforcement remained a priority. This makes a reduction in actual drug volume the most likely explanation.
To corroborate these government statistics with real-world experiences, the researchers turned to an unconventional source of data. They analyzed discussions on the social media platform Reddit. Users on this site frequently discuss the quality and availability of drugs in specific online communities or “subreddits.”
The researchers tracked the use of the word “drought” and related terms in communities such as r/fentanyl and r/heroin. They manually verified the posts to ensure the users were discussing a shortage of fentanyl rather than other substances. The analysis showed a spike in user complaints about a drought beginning in July 2023.
These complaints intensified throughout the year. The discussions became so prevalent that moderators of the forums temporarily banned posts about shortages to comply with site rules. Once the ban was lifted in mid-2024, mentions of a drought surged again. This timeline aligns closely with the reduction in overdose deaths and the decline in drug purity recorded by the government.
A central challenge in the study was identifying the source of the disruption. The researchers needed to determine if the supply shock originated in Mexico, where cartels produce fentanyl for the US market, or further upstream in the supply chain. To do this, they compared the situation in the United States with that of Canada.
Canada also suffers from a fentanyl crisis, but its supply chain is distinct. While the United States receives finished fentanyl trafficked from Mexico, Canadian traffickers largely import precursor chemicals and manufacture the drug domestically. Despite these different production methods, both countries rely on chemical precursors that originate in China.
If the supply shock were caused by law enforcement actions at the US-Mexico border or conflicts between Mexican cartels, the Canadian market should have remained relatively stable. However, the data showed that Canada experienced a similar disruption. Opioid-related deaths in Canada began to decline in the third quarter of 2023.
Canadian health data mirrored the trends seen in the United States. Emergency medical services reported fewer responses to suspected opioid poisonings. Hospitalizations related to opioids also fell. Additionally, Canadian lab data showed a shift where dealers began substituting fentanyl with fentanyl analogs, a behavior often seen when the primary drug is scarce.
The synchronized downturn in both nations points to a bottleneck at the source of the chemicals they share. The researchers suggest that actions taken by the Chinese government are the most plausible explanation. This shift aligned with a pivotal meeting between President Joe Biden and Chinese President Xi Jinping in November 2023. The summit resulted in an agreement to increase cooperation on drug enforcement between the two nations.
Following this diplomatic breakthrough, China tightened regulations on the production and export of chemicals used to make synthetic opioids. These regulatory actions included the removal of online advertisements for precursor chemicals and the shutdown of various marketplaces. The Chinese government also issued notices warning chemical companies against selling substances that could be used for illicit drug production.
The Drug Enforcement Administration noted in a 2025 assessment that Chinese suppliers had become “wary” of selling these chemicals to international buyers. The assessment indicated that suppliers were aware of the increased scrutiny resulting from the government’s compliance with updated United Nations counter-narcotics treaties. The timeline of these enforcement actions in China closely matches the drop in purity and deaths seen in North America.
The study implies that diplomatic pressure and international cooperation can yield tangible public health benefits. The reduction in the flow of raw materials appears to have achieved what domestic law enforcement struggles to accomplish. Arresting street-level dealers rarely impacts the overall availability of drugs, but choking off the supply of essential chemicals affects the entire market.
The authors note that these positive changes may not be permanent. Drug trafficking organizations are highly adaptive businesses. History shows that when one supply route is closed, traffickers often find alternatives. They may stockpile chemicals, develop new synthesis methods, or source precursors from other nations such as India.
There are limitations to the analysis presented in the study. Because this was an observational study of national policies, there is no control group to confirm causation. It is theoretically possible that some unmeasured factor affecting both the United States and Canada caused the decline. However, alternative explanations such as the waning of the COVID-19 pandemic do not fit the timing of the data.
The data on drug purity also has limitations. The samples analyzed by the government are not always from the retail level. Some may be wholesale seizures, which naturally have higher purity. Changes in the mix of seizure types could influence the averages, though the trend across both pills and powder remains consistent.
Despite these caveats, the research offers a coherent explanation for a sudden shift in a long-standing public health crisis. It suggests that the illicit fentanyl trade is more vulnerable to upstream disruptions than previously thought. The findings highlight the value of monitoring global chemical supply chains as a method of drug control.
The study authors recommend that policymakers use this period of reduced supply to expand treatment and prevention programs. While the current drought in fentanyl availability has saved lives, demand for the drug persists. Strengthening the support systems for those with substance use disorders could help sustain the reduction in mortality even if supply chains eventually recover.
The study, “Did the illicit fentanyl trade experience a supply shock? A synthesis of government and social media data suggests a disruption, possibly tied to events in China,” was authored by Kasey Vangelov, Keith Humphreys, Jonathan P. Caulkins, Harold Pollack, Bryce Pardo, and Peter Reuter.
